Clinical evaluation of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of human infrabony defects.

Source:http://linkedlifedata.com/resource/pubmed/id/18320242

Download in:

View as

General Info

PMID
18320242